Howard Lazarus insider trades

Open-market stock purchases and sales by Howard Lazarus, Chief Medical Officer at Avalyn Pharma Inc, from SEC Form 4 filings since Apr 29, 2026.

Recent trades

DateStockTradeValue
Apr 29, 2026AVLN Avalyn Pharma IncBought (not open market)—

Companies traded

  • AVLN Avalyn Pharma Inc: other filings, last Apr 29, 2026

Get free alerts when Howard Lazarus files a new trade →